BLU-285

· Blueprint Medicines Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BLU-285, covering 2021-06-22 to 2021-06-22. Get the full timeline:

Most recent: Clinical Trial Update: (NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors [Phase 1]

See pricing